Menu
US
enhance-protac-drug-discovery-btk-case-study
Application Note

Enhance PROTAC Drug Discovery with AlphaLISA and HTRF Kits

A Bruton Tyrosine Kinase (BTK) case study

PROteolysis Targeting Chimeras (PROTACs) are one of the latest trending tools used in drug discovery.

This note compiles experiments carried out to characterize PROTAC compounds using Bruton Tyrosine Kinase (BTK) as a model on Ramos cells. Both AlphaLISA and HTRF technologies were used in biochemical and cell-based contexts.

Featured in this note:

  • Assay principle and workflow
  • Consistent results (data and graphs)
  • Informative materials and methods, including references

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Enhance PROTAC Drug Discovery with AlphaLISA and HTRF Kits

Download Application Note